Development of combination therapy to delay resistance in BRAF-inhibitor treated melanoma

Seretis A, Cappellano G, Bellmann L, Hornsteiner F, Tripp CH, Ortner-Tobider D, Mullins DW, Amon L, Lehmann C, Dudziak D, Stoitzner P (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Experimental Dermatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: E63-E63

Conference Proceedings Title: EXPERIMENTAL DERMATOLOGY

Authors with CRIS profile

Lukas Amon Department of Dermatology Christian Lehmann Department of Dermatology Diana Dudziak Professur für die Biologie Dendritischer Zellen

Involved external institutions

Dartmouth College US United States (USA) (US) Medizinische Universität Innsbruck AT Austria (AT) University of Eastern Piedmont / Università degli Studi del Piemonte Orientale "Amedeo Avogadro" IT Italy (IT)

How to cite

APA:

Seretis, A., Cappellano, G., Bellmann, L., Hornsteiner, F., Tripp, C.H., Ortner-Tobider, D.,... Stoitzner, P. (2021). Development of combination therapy to delay resistance in BRAF-inhibitor treated melanoma. In EXPERIMENTAL DERMATOLOGY (pp. E63-E63). HOBOKEN: WILEY.

MLA:

Seretis, A., et al. "Development of combination therapy to delay resistance in BRAF-inhibitor treated melanoma." Proceedings of the EXPERIMENTAL DERMATOLOGY HOBOKEN: WILEY, 2021. E63-E63.

BibTeX: Download